Company intelligence / Profile preview

DentCell

Sunrise, Florida, United States

Ownership: Private
Development stage: Other

Overview

DentaCell focuses on banking dental stem cells from baby teeth, wisdom teeth, and permanent teeth for future therapeutic use. The company is developing products for dental gum healing applications but dental pulp stem cells are currently only being used in laboratory settings and are not yet approved for medical treatments.

Therapeutic areas: CardiovascularNeurologyOtherRheumatology
Modalities: Stem cell therapyCell therapy
Industry: Biotech

Partnerships

Bioheart

Beyond the preview

Go deeper on DentCell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DentCell.

Explore the full profile